Literature DB >> 2197503

Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing.

I Darby1, O Skalli, G Gabbiani.   

Abstract

We have studied the expression of alpha-smooth muscle actin, smooth muscle myosin, and desmin in granulation tissue during the healing of an open wound in the rat by means of electron microscopy and immunohistochemistry, at the light and electron microscopic levels, using specific antibodies directed against these proteins. Important amounts of the three antigens were always expressed in pericytic and/or smooth muscle cells of neoformed small vessels. In fibroblastic cells, microfilaments were absent 4 days after wounding but accumulated gradually, starting from the 6th up to the 15th day; at this time, they were evident in about 70% of fibroblastic cells (myofibroblasts). They then regressed progressively, and on the 30th day, microfilaments were no longer present in scar fibroblasts. alpha-Smooth muscle actin, but not smooth muscle myosin and desmin, was always present in microfilament bundles of myofibroblasts. The staining intensity was progressive from the 6th to the 15th day and decreased thereafter; no staining was seen at the 30th day. Between the 20th and the 25th day, many apoptotic figures were seen in fibroblastic and endothelial cells, suggesting that apoptosis is the mechanism of their disappearance. We conclude that myofibroblasts develop gradually from granulation tissue fibroblasts and temporarily express a marker of smooth muscle differentiation. These results may be relevant for the understanding of the mechanisms of normal and pathologic wound healing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197503

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  279 in total

1.  Impaired wound contraction in stromelysin-1-deficient mice.

Authors:  K M Bullard; L Lund; J S Mudgett; T N Mellin; T K Hunt; B Murphy; J Ronan; Z Werb; M J Banda
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

Review 2.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

3.  Diffuse Inflammatory Pseudotumor of the Testis, the Epididymis and the Spermatic Cord.

Authors:  Zsolt Orosz
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

4.  A cell-based constitutive relation for bio-artificial tissues.

Authors:  G I Zahalak; J E Wagenseil; T Wakatsuki; E L Elson
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

Review 5.  Myofibroblasts: paracrine cells important in health and disease.

Authors:  D W Powell
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

6.  Contractile responses of smooth muscle cells differentiated from rat neural stem cells.

Authors:  Kazuhiko Oishi; Yasuhiro Ogawa; Shuji Gamoh; Masaatsu K Uchida
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

7.  Possible involvement of myofibroblasts in cellular recovery of uranyl acetate-induced acute renal failure in rats.

Authors:  D F Sun; Y Fujigaki; T Fujimoto; K Yonemura; A Hishida
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

8.  Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts.

Authors:  Boris Hinz; Vera Dugina; Christoph Ballestrem; Bernhard Wehrle-Haller; Christine Chaponnier
Journal:  Mol Biol Cell       Date:  2003-02-21       Impact factor: 4.138

9.  Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.

Authors:  A J Baker; A Mooney; J Hughes; D Lombardi; R J Johnson; J Savill
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Morphological and immunochemical differences between keloid and hypertrophic scar.

Authors:  H P Ehrlich; A Desmoulière; R F Diegelmann; I K Cohen; C C Compton; W L Garner; Y Kapanci; G Gabbiani
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.